Marketing firm Treewards Inc.

NEW YORK, April 5, 2012 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Allos Therapeutics,

BOSTON, April 5, 2012 /PRNewswire/ -- Block & Leviton LLP, a Boston based law firm representing investors nationwide, is investigating possible breaches of fiduciary duties by the Board

WESTMINSTER, Colo., Jan. 8 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. today announced that the Company will participate in the 2007 JP Morgan Healthcare Conference, to be held January 8 -11 in San Francisco. Paul L.

Allos Therapeutics has reported that a trial of its cancer drug PDX can go ahead after the Data Monitoring Committee conducted an interim analysis of safety data and recommended that the study continue.